Amélia Déguilhem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amélia Déguilhem has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Adel Mebarki
Kap Code, Paris, France
2 shared publications - Emilie Jouanjus
Faculty of Health University of Toulouse Toulouse France
2 shared publications - Guy Fagherazzi
Deep Digital Phenotyping Research Unit, Department of Precision Health Luxembourg Institute of Health Strassen Luxembourg
2 shared publications - Joelle Malaab
Kap Code, 4 rue de Cléry, Paris, 75002, France, 33 0764853053
2 shared publications - Manissa Talmatkadi
Kap Code, Paris, France
2 shared publications - Maryse Lapeyre-Mestre
Faculty of Health University of Toulouse Toulouse France
2 shared publications
Latest Publications
- Open Access
- 14 June 2026
- Published by Springer Nature in CNS Drugs
- Vol. 40 (8) , 1149-1164
Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase® Data
Background and Objectives Despite increasing global use of cannabis and cannabinoids, comprehensive data on their safety profile remain limited. This study aimed to examine global patterns in pharmacovigilance reports associated with cannabis and cannabinoids, irrespective of regulatory status or context of use. Methods VigiBase®, the World Health Organisation’s global database of individual case safety reports (ICSRs), was analysed in a retrospective cross-sectional study from 1 January 2020 to 31 December 2024 (data extraction: 19 February 2025). “Cannabis ICSRs” included at least one mention of Cannabis sativa or cannabinoids. Temporal and geographical distributions, reported substances, and suspected adverse drug reactions (ADRs) were assessed. A single ICSR may include multiple substance mentions and several suspected ADRs. Results Among 7,007,689 records, 9983 cannabis ICSRs were identified across 44 countries, comprising 12,538 cannabis or cannabinoid mentions and 27,593 suspected ADRs. The median age was 29 years, with 62.7% males. Most cases were serious (68.5%), including hospitalisation (45.9%) and death (28.6%). The highest reporting rates relative to national ICSR numbers were observed in France, Greece, and the USA. The most frequently reported substances were Cannabis sativa (n = 5951) and cannabidiol (n = 2967). Suspected ADRs were predominantly psychiatric (29.2%) and nervous system disorders (16.8%), with gastrointestinal, respiratory, and cardiac disorders less common (6.4%, 3.6%, and 2.8%). Conclusions This study provides the first comprehensive global overview of suspected ADRs associated with cannabis and cannabinoids. The predominance of serious cases, particularly psychiatric and nervous system reactions, highlights important safety considerations, offering key insights to inform clinical practice and risk assessment worldwide.
- 14 June 2026
- Published by Springer Nature in CNS Drugs
- Vol. 40 (8) , 1149-1164
Open AccessCannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase® Data
Background and Objectives Despite increasing global use of cannabis and cannabinoids, comprehensive data on their safety profile remain limited. This study aimed to examine global patterns in pharmacovigilance reports associated with cannabis and cannabinoids, irrespective of regulatory status or context of use. Methods VigiBase®, the World Health Organisation’s global database of individual case safety reports (ICSRs), was analysed in a retrospective cross-sectional study from 1 January 2020 to 31 December 2024 (data extraction: 19 February 2025). “Cannabis ICSRs” included at least one mention of Cannabis sativa or cannabinoids. Temporal and geographical distributions, reported substances, and suspected adverse drug reactions (ADRs) were assessed. A single ICSR may include multiple substance mentions and several suspected ADRs. Results Among 7,007,689 records, 9983 cannabis ICSRs were identified across 44 countries, comprising 12,538 cannabis or cannabinoid mentions and 27,593 suspected ADRs. The median age was 29 years, with 62.7% males. Most cases were serious (68.5%), including hospitalisation (45.9%) and death (28.6%). The highest reporting rates relative to national ICSR numbers were observed in France, Greece, and the USA. The most frequently reported substances were Cannabis sativa (n = 5951) and cannabidiol (n = 2967). Suspected ADRs were predominantly psychiatric (29.2%) and nervous system disorders (16.8%), with gastrointestinal, respiratory, and cardiac disorders less common (6.4%, 3.6%, and 2.8%). Conclusions This study provides the first comprehensive global overview of suspected ADRs associated with cannabis and cannabinoids. The predominance of serious cases, particularly psychiatric and nervous system reactions, highlights important safety considerations, offering key insights to inform clinical practice and risk assessment worldwide.
- Top Cited PapersOpen Access
Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis
Background Awareness has recently risen about the potential associated risks to the cardiovascular health of cannabis users. The objective was to evaluate the possible association between major adverse cardiovascular events (MACE) and the use of cannabis or cannabinoids. Methods Original pharmacoepidemiological studies providing risk estimates on cannabis-related MACE (ie, cardiovascular death, non-fatal acute coronary syndrome (ACS) including myocardial infarction (MI) or non-fatal stroke) published from 1 January 2016 to 31 January 2023 were included in the systematic review exploring PubMed, Web of Science and Scopus (last search: 20 September 2023). Design, duration, baseline characteristics, exposure, inclusion criteria, sample size, effect size and confusing factors, including exposure to psychoactive substances, were extracted. Study quality was assessed using the ROBINS-E (risk of bias in non-randomised studies—of exposures) tool. In the meta-analysis, adjusted effect estimates and their 95% CIs were pooled using a DerSimonian and Laird random effect model with inverse variance weighting based on the type of outcome (PROSPERO: CRD42023401401). Results Overall, 24 articles were included from 3012 initial records, including 17 cross-sectional studies, 6 cohort studies and 1 case-control study. Exposure corresponded to the use of cannabis in all studies, with one focused on medical cannabis. The estimated risk ratio (RR) was 1.29 (95% CI 1.05 to 1.59) for ACS, 1.20 (1.13 to 1.26) for stroke and 2.10 (1.29 to 3.42) for cardiovascular death. As measured in two studies, no statistically significant association was found for the composite outcome combining ACS and stroke. The focused analysis restricted to cohort studies yielded comparable results to the primary model (RR=1.32, 1.01 to 1.73). Conclusions This systematic review and meta-analysis uses an original approach centred on real-world data. The findings reveal positive associations between cannabis use and MACE. These findings should encourage investigating cannabis use in all patients presenting with serious cardiovascular disorders. PROSPERO registration number CRD42023401401.
Top Cited PapersOpen AccessCardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis
Background Awareness has recently risen about the potential associated risks to the cardiovascular health of cannabis users. The objective was to evaluate the possible association between major adverse cardiovascular events (MACE) and the use of cannabis or cannabinoids. Methods Original pharmacoepidemiological studies providing risk estimates on cannabis-related MACE (ie, cardiovascular death, non-fatal acute coronary syndrome (ACS) including myocardial infarction (MI) or non-fatal stroke) published from 1 January 2016 to 31 January 2023 were included in the systematic review exploring PubMed, Web of Science and Scopus (last search: 20 September 2023). Design, duration, baseline characteristics, exposure, inclusion criteria, sample size, effect size and confusing factors, including exposure to psychoactive substances, were extracted. Study quality was assessed using the ROBINS-E (risk of bias in non-randomised studies—of exposures) tool. In the meta-analysis, adjusted effect estimates and their 95% CIs were pooled using a DerSimonian and Laird random effect model with inverse variance weighting based on the type of outcome (PROSPERO: CRD42023401401). Results Overall, 24 articles were included from 3012 initial records, including 17 cross-sectional studies, 6 cohort studies and 1 case-control study. Exposure corresponded to the use of cannabis in all studies, with one focused on medical cannabis. The estimated risk ratio (RR) was 1.29 (95% CI 1.05 to 1.59) for ACS, 1.20 (1.13 to 1.26) for stroke and 2.10 (1.29 to 3.42) for cardiovascular death. As measured in two studies, no statistically significant association was found for the composite outcome combining ACS and stroke. The focused analysis restricted to cohort studies yielded comparable results to the primary model (RR=1.32, 1.01 to 1.73). Conclusions This systematic review and meta-analysis uses an original approach centred on real-world data. The findings reveal positive associations between cannabis use and MACE. These findings should encourage investigating cannabis use in all patients presenting with serious cardiovascular disorders. PROSPERO registration number CRD42023401401.
- 11 September 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (3) , 1080-1088
Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study
We examined the prospective associations between nicotine dependence and the likelihood of psychiatric and substance use disorders in the general adult population. Participants came from a nationally representative sample of US adults aged 18 years or older, who were interviewed 3 years apart in the National Epidemiologic Survey on Alcohol and Related Conditions (Wave 1, 2001–2002; Wave 2, 2004–2005). The primary analyses were limited to 32,671 respondents (13,751 male (47.9% weighted); mean age of 45 years (SD = 0.18)) who were interviewed in both waves. We used multiple regression and propensity score matching (PSM) to estimate the strength of independent associations between nicotine dependence related to the use of tobacco products at Wave 1 and incident psychiatric disorders at Wave 2. Psychiatric disorders were measured with a structured interview (Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV). All analyses adjusted for multiple potential confounders, including childhood (family history of substance use disorders, parental loss, vulnerable family environment), early-adolescence (self-esteem, social deviance, conduct disorder), late-adolescence (education, personality and psychiatric disorders), adulthood (divorce, stressful life events, social deviance, quality of life, history of alcohol or other substance use disorder), and sociodemographic factors. Multiple regression analysis and PSM converged in indicating that nicotine dependence was associated with significantly increased incidence of any psychiatric disorder (OR = 1.39(95%CI:1.20;1.60)), including substance use disorders (OR = 1.91(95%CI:1.47;2.47)), and anxiety disorders (OR = 1.31(95%CI:1.06;1.62)). Population Attributable Risk Proportions were substantial, ranging from 12.5%(95%CI:8.10;17.0) for any psychiatric disorder to 33.3%(95%CI:18.7;48.0) for any other drug use disorder. Supplementary analyses also indicated significant associations between nicotine dependence and persistence of psychiatric and substance use disorders among patients having a disorder at Wave 1. In the general adult population, nicotine dependence is associated with an increased likelihood for several psychiatric and substance use disorders. Given its high prevalence, these findings have important public health implications.
- 11 September 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (3) , 1080-1088
Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study
We examined the prospective associations between nicotine dependence and the likelihood of psychiatric and substance use disorders in the general adult population. Participants came from a nationally representative sample of US adults aged 18 years or older, who were interviewed 3 years apart in the National Epidemiologic Survey on Alcohol and Related Conditions (Wave 1, 2001–2002; Wave 2, 2004–2005). The primary analyses were limited to 32,671 respondents (13,751 male (47.9% weighted); mean age of 45 years (SD = 0.18)) who were interviewed in both waves. We used multiple regression and propensity score matching (PSM) to estimate the strength of independent associations between nicotine dependence related to the use of tobacco products at Wave 1 and incident psychiatric disorders at Wave 2. Psychiatric disorders were measured with a structured interview (Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV). All analyses adjusted for multiple potential confounders, including childhood (family history of substance use disorders, parental loss, vulnerable family environment), early-adolescence (self-esteem, social deviance, conduct disorder), late-adolescence (education, personality and psychiatric disorders), adulthood (divorce, stressful life events, social deviance, quality of life, history of alcohol or other substance use disorder), and sociodemographic factors. Multiple regression analysis and PSM converged in indicating that nicotine dependence was associated with significantly increased incidence of any psychiatric disorder (OR = 1.39(95%CI:1.20;1.60)), including substance use disorders (OR = 1.91(95%CI:1.47;2.47)), and anxiety disorders (OR = 1.31(95%CI:1.06;1.62)). Population Attributable Risk Proportions were substantial, ranging from 12.5%(95%CI:8.10;17.0) for any psychiatric disorder to 33.3%(95%CI:18.7;48.0) for any other drug use disorder. Supplementary analyses also indicated significant associations between nicotine dependence and persistence of psychiatric and substance use disorders among patients having a disorder at Wave 1. In the general adult population, nicotine dependence is associated with an increased likelihood for several psychiatric and substance use disorders. Given its high prevalence, these findings have important public health implications.
- Open Access
- 22 November 2022
- Published by JMIR Publications Inc. in JMIR Infodemiology
- Vol. 2 (2) , e39849
Identifying Profiles and Symptoms of Patients With Long COVID in France: Data Mining Infodemiology Study Based on Social Media
Background: Long COVID—a condition with persistent symptoms post COVID-19 infection—is the first illness arising from social media. In France, the French hashtag #ApresJ20 described symptoms persisting longer than 20 days after contracting COVID-19. Faced with a lack of recognition from medical and official entities, patients formed communities on social media and described their symptoms as long-lasting, fluctuating, and multisystemic. While many studies on long COVID relied on traditional research methods with lengthy processes, social media offers a foundation for large-scale studies with a fast-flowing outburst of data. Objective: We aimed to identify and analyze Long Haulers’ main reported symptoms, symptom co-occurrences, topics of discussion, difficulties encountered, and patient profiles. Methods: Data were extracted based on a list of pertinent keywords from public sites (eg, Twitter) and health-related forums (eg, Doctissimo). Reported symptoms were identified via the MedDRA dictionary, displayed per the volume of posts mentioning them, and aggregated at the user level. Associations were assessed by computing co-occurrences in users’ messages, as pairs of preferred terms. Discussion topics were analyzed using the Biterm Topic Modeling; difficulties and unmet needs were explored manually. To identify patient profiles in relation to their symptoms, each preferred term’s total was used to create user-level hierarchal clusters. Results: Between January 1, 2020, and August 10, 2021, overall, 15,364 messages were identified as originating from 6494 patients of long COVID or their caregivers. Our analyses revealed 3 major symptom co-occurrences: asthenia-dyspnea (102/289, 35.3%), asthenia-anxiety (65/289, 22.5%), and asthenia-headaches (50/289, 17.3%). The main reported difficulties were symptom management (150/424, 35.4% of messages), psychological impact (64/424,15.1%), significant pain (51/424, 12.0%), deterioration in general well-being (52/424, 12.3%), and impact on daily and professional life (40/424, 9.4% and 34/424, 8.0% of messages, respectively). We identified 3 profiles of patients in relation to their symptoms: profile A (n=406 patients) reported exclusively an asthenia symptom; profile B (n=129) expressed anxiety (n=129, 100%), asthenia (n=28, 21.7%), dyspnea (n=15, 11.6%), and ageusia (n=3, 2.3%); and profile C (n=141) described dyspnea (n=141, 100%), and asthenia (n=45, 31.9%). Approximately 49.1% of users (79/161) continued expressing symptoms after more than 3 months post infection, and 20.5% (33/161) after 1 year. Conclusions: Long COVID is a lingering condition that affects people worldwide, physically and psychologically. It impacts Long Haulers’ quality of life, everyday tasks, and professional activities. Social media played an undeniable role in raising and delivering Long Haulers’ voices and can potentially rapidly provide large volumes of valuable patient-reported information. Since long COVID was a self-titled condition by patients themselves via social media, it is imperative to continuously include their perspectives in related research. Our results can help design patient-centric instruments to be further used in clinical practice to better capture meaningful dimensions of long COVID.
- 22 November 2022
- Published by JMIR Publications Inc. in JMIR Infodemiology
- Vol. 2 (2) , e39849
Open AccessIdentifying Profiles and Symptoms of Patients With Long COVID in France: Data Mining Infodemiology Study Based on Social Media
Background: Long COVID—a condition with persistent symptoms post COVID-19 infection—is the first illness arising from social media. In France, the French hashtag #ApresJ20 described symptoms persisting longer than 20 days after contracting COVID-19. Faced with a lack of recognition from medical and official entities, patients formed communities on social media and described their symptoms as long-lasting, fluctuating, and multisystemic. While many studies on long COVID relied on traditional research methods with lengthy processes, social media offers a foundation for large-scale studies with a fast-flowing outburst of data. Objective: We aimed to identify and analyze Long Haulers’ main reported symptoms, symptom co-occurrences, topics of discussion, difficulties encountered, and patient profiles. Methods: Data were extracted based on a list of pertinent keywords from public sites (eg, Twitter) and health-related forums (eg, Doctissimo). Reported symptoms were identified via the MedDRA dictionary, displayed per the volume of posts mentioning them, and aggregated at the user level. Associations were assessed by computing co-occurrences in users’ messages, as pairs of preferred terms. Discussion topics were analyzed using the Biterm Topic Modeling; difficulties and unmet needs were explored manually. To identify patient profiles in relation to their symptoms, each preferred term’s total was used to create user-level hierarchal clusters. Results: Between January 1, 2020, and August 10, 2021, overall, 15,364 messages were identified as originating from 6494 patients of long COVID or their caregivers. Our analyses revealed 3 major symptom co-occurrences: asthenia-dyspnea (102/289, 35.3%), asthenia-anxiety (65/289, 22.5%), and asthenia-headaches (50/289, 17.3%). The main reported difficulties were symptom management (150/424, 35.4% of messages), psychological impact (64/424,15.1%), significant pain (51/424, 12.0%), deterioration in general well-being (52/424, 12.3%), and impact on daily and professional life (40/424, 9.4% and 34/424, 8.0% of messages, respectively). We identified 3 profiles of patients in relation to their symptoms: profile A (n=406 patients) reported exclusively an asthenia symptom; profile B (n=129) expressed anxiety (n=129, 100%), asthenia (n=28, 21.7%), dyspnea (n=15, 11.6%), and ageusia (n=3, 2.3%); and profile C (n=141) described dyspnea (n=141, 100%), and asthenia (n=45, 31.9%). Approximately 49.1% of users (79/161) continued expressing symptoms after more than 3 months post infection, and 20.5% (33/161) after 1 year. Conclusions: Long COVID is a lingering condition that affects people worldwide, physically and psychologically. It impacts Long Haulers’ quality of life, everyday tasks, and professional activities. Social media played an undeniable role in raising and delivering Long Haulers’ voices and can potentially rapidly provide large volumes of valuable patient-reported information. Since long COVID was a self-titled condition by patients themselves via social media, it is imperative to continuously include their perspectives in related research. Our results can help design patient-centric instruments to be further used in clinical practice to better capture meaningful dimensions of long COVID.
- Open Access
- 25 May 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Identifying profiles and symptoms of Long Covid patients: a data mining infodemiology study based on French social media (Preprint)
BACKGROUND Long Covid – a condition with persistent symptoms post Covid-19 infection - is the first illness arising from Social Media (SM). Faced with a lack of recognition from medical and official entities, patients formed communities on SM and described their symptoms as long-lasting, fluctuating and multi-systemic. While many studies on Long Covid relied on traditional research methods that include lengthy processes, SM offers a foundation for large-scale studies with a fast-flowing outburst of data. OBJECTIVE To identify and analyze Long Haulers’ main reported symptoms, symptom co-occurrences, topics of discussion, difficulties encountered, and patient profiles. METHODS Data extraction was performed based on a list of pertinent keywords. Reported symptoms were identified via the MedDRA dictionary, displayed according to the volume of posts mentioning them, then aggregated at the user level. Associations were assessed by computing co-occurrences in users’ messages, as pairs of Preferred Terms (PTs). Discussion topics were analyzed using the Biterm Topic Modeling; difficulties and unmet needs were explored manually. To identify patient profiles in relation to their symptoms, the total of each PT was used to create hierarchal clusters at the user level. RESULTS A total of 15 364 messages were identified as originating from 6 494 patients of Long Covid or their caregivers. Our analyses revealed three major symptom co-occurrences: asthenia|dyspnea (35,3%), asthenia|anxiety (22.5%), and asthenia|headaches (17.3%). The main reported difficulties were “the management of symptoms” (35.4% of messages), “psychological impact” (15.1%), “significant pain” (12,0%), “deterioration in the general well-being (12,3%), and “impact on daily and professional life” (9,4% and 8,0% of messages, respectively). We identified three profiles of patients in relation to their symptoms: Profile A (n= 406 patients) reported exclusively a symptom of Asthenia (100% of patients), Profile B (n= 129 patients) expressed Anxiety (100% of patients), Asthenia (22%), Dyspnea (12%), Ageusia (2%); and Profile C (n=141 patients) described Dyspnea (100% of patients) and Asthenia (32%). About 50% of users continued expressing symptoms after more than 6 months post-infection, and 16.1% after 1 year. CONCLUSIONS Long Covid is a lingering condition that affects people across the globe, physically and psychologically. It impacts Long Haulers’ quality of life, everyday tasks, and professional activities. Social Media played an undeniable role in raising and delivering Long Haulers’ voices. It also has the potential to rapidly provide large volumes of valuable patient-reported information. Considering the fact that Long Covid was a self-titled condition by patients themselves via SM, it is imperative to continuously include their perspectives in related research. The data presented in this study can help design patient-centric instruments to be further used in clinical practice to better capture meaningful dimensions of Long Covid.
- 25 May 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessIdentifying profiles and symptoms of Long Covid patients: a data mining infodemiology study based on French social media (Preprint)
BACKGROUND Long Covid – a condition with persistent symptoms post Covid-19 infection - is the first illness arising from Social Media (SM). Faced with a lack of recognition from medical and official entities, patients formed communities on SM and described their symptoms as long-lasting, fluctuating and multi-systemic. While many studies on Long Covid relied on traditional research methods that include lengthy processes, SM offers a foundation for large-scale studies with a fast-flowing outburst of data. OBJECTIVE To identify and analyze Long Haulers’ main reported symptoms, symptom co-occurrences, topics of discussion, difficulties encountered, and patient profiles. METHODS Data extraction was performed based on a list of pertinent keywords. Reported symptoms were identified via the MedDRA dictionary, displayed according to the volume of posts mentioning them, then aggregated at the user level. Associations were assessed by computing co-occurrences in users’ messages, as pairs of Preferred Terms (PTs). Discussion topics were analyzed using the Biterm Topic Modeling; difficulties and unmet needs were explored manually. To identify patient profiles in relation to their symptoms, the total of each PT was used to create hierarchal clusters at the user level. RESULTS A total of 15 364 messages were identified as originating from 6 494 patients of Long Covid or their caregivers. Our analyses revealed three major symptom co-occurrences: asthenia|dyspnea (35,3%), asthenia|anxiety (22.5%), and asthenia|headaches (17.3%). The main reported difficulties were “the management of symptoms” (35.4% of messages), “psychological impact” (15.1%), “significant pain” (12,0%), “deterioration in the general well-being (12,3%), and “impact on daily and professional life” (9,4% and 8,0% of messages, respectively). We identified three profiles of patients in relation to their symptoms: Profile A (n= 406 patients) reported exclusively a symptom of Asthenia (100% of patients), Profile B (n= 129 patients) expressed Anxiety (100% of patients), Asthenia (22%), Dyspnea (12%), Ageusia (2%); and Profile C (n=141 patients) described Dyspnea (100% of patients) and Asthenia (32%). About 50% of users continued expressing symptoms after more than 6 months post-infection, and 16.1% after 1 year. CONCLUSIONS Long Covid is a lingering condition that affects people across the globe, physically and psychologically. It impacts Long Haulers’ quality of life, everyday tasks, and professional activities. Social Media played an undeniable role in raising and delivering Long Haulers’ voices. It also has the potential to rapidly provide large volumes of valuable patient-reported information. Considering the fact that Long Covid was a self-titled condition by patients themselves via SM, it is imperative to continuously include their perspectives in related research. The data presented in this study can help design patient-centric instruments to be further used in clinical practice to better capture meaningful dimensions of Long Covid.